Status:
COMPLETED
Evaluating the Feasibility of Using M-Health to Improve Serum Glucose Logs
Lead Sponsor:
Leslie Balcazar De Martinez
Conditions:
Gestational Diabetes Mellitus
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Gestational diabetes mellitus (GDM) can cause adverse outcomes for the mother and fetus due to hyperglycemia. The purpose of this study is to evaluate the feasibility of improving pregnant women's glu...
Detailed Description
Study Question: Does use of a Bluetooth enabled serum glucose monitor in conjunction with a mobile health application improve pregnant women's glucose log completion? This pilot study proposes that th...
Eligibility Criteria
Inclusion
- At least 18 years old
- Willing and able to give informed consent
- Diagnosis of gestational diabetes
- Speak English and/or Spanish
- Have ownership of a smartphone capable of running the mobile health application
- Willing to download the iGluco mobile phone application
Exclusion
- Have knowledge that their delivery will occur prior to completion of the required eight weeks of glucose logs
- Possess a Bluetooth enabled glucometer
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 28 2018
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT03340311
Start Date
November 1 2017
End Date
April 28 2018
Last Update
May 1 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Virginia Maternal Fetal Medicine Clinic
Charlottesville, Virginia, United States, 22901